Normal function · from ai-gene-review (Q08J23, commit 79fe13b38970) · AI-generated, not KB evidence

RNA cytosine-5 methyltransferase, the human orthologue of yeast Trm4, and the enzyme responsible for most 5-methylcytosine in human RNA. NSUN2 uses S-adenosyl-L-methionine and a catalytic cysteine to methylate cytosines in transfer RNA: the wobble base C34 of intron-containing pre-tRNA-Leu(CAA), and C47-C50 in the variable loop of many cytoplasmic tRNAs. It is imported into the mitochondrial matrix, where it makes m5C at positions 48-50 of several mitochondrial tRNAs, and it is the sole enzyme that methylates C69 of the vault RNA VTRNA1.1, thereby directing its processing into small vault RNAs. The methylation it deposits protects tRNAs from stress-induced endonucleolytic cleavage, and loss of the enzyme alters translation, tRNA-fragment production and the differentiation of skin, hair follicle and neural stem cells; biallelic loss-of-function variants cause autosomal-recessive intellectual disability and a Dubowitz-like syndrome. NSUN2 is predominantly nuclear and nucleolar, with cytoplasmic and mitochondrial pools, and it has been detected in secreted exosomes. NSUN2 also methylates messenger RNA, and m5C in mRNA has been linked to nuclear export via ALYREF and to transcript stabilisation via YBX1; this substrate class is genuinely contested, because the mapping methods used to locate mRNA m5C sites - bisulfite sequencing, Aza-IP and miCLIP - agree poorly with one another, mRNA structure generates false-positive bisulfite signals, and the modification occurs at roughly one in several thousand cytosines, which leaves it unclear how the proposed reader proteins discriminate modified transcripts.

NSUN2 is the human Trm4 orthologue and the principal RNA m5C writer of the cell. Using SAM and a motif VI catalytic cysteine, it methylates C34 of intron-containing pre-tRNA-Leu(CAA) and C47-C50 in the variable loop of many cytoplasmic tRNAs, and the same enzyme, imported into the mitochondrial matrix, makes m5C at positions 48-50 of several mitochondrial tRNAs. The activity has been reconstituted in vitro with purified protein and mapped product positions, and the corresponding modifications are lost in NSUN2-null mouse tissue, NSUN2 knockout human cells and cells from patients with biallelic NSUN2 variants. The methylation stabilises tRNA against stress-induced endonucleolytic cleavage.
Substrate recognition by NSUN2 extends beyond tRNA. It is the only enzyme that methylates C69 of the vault RNA VTRNA1.1, and that single modification determines how VTRNA1.1 is processed into small vault RNAs, so NSUN2 binding and methylation of a structured non-coding RNA has a defined downstream consequence. NSUN2 is also recovered in mRNA interactome capture and recognises a specific structural motif in exosome-enriched transcripts. This binding function is listed separately from the catalytic function because in several of these contexts the binding, rather than the chemistry, is what has been directly demonstrated.
molecular function: RNA binding · locations: nucleus; cytoplasm
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Autosomal Recessive Non-Syndromic Intellectual Disability causative germline
mechanism: Loss of a Gene-Specific Molecular Function Required by Developing Neurons
subtype: MRT5
scoped to subtype: MRT5
Autosomal Dominant Cerebellar Ataxia Deafness and Narcolepsy no genetic record
mechanism: Aberrant DNMT1-NSUN2 RNA m5C Methylation
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
syndromic intellectual disability MONDO:0000508 AR Definitive
2023-10-18
no dismech entry
RASopathy MONDO:0021060 AR Disputed
2019-02-04
no dismech entry

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.